• 1
    Baran K, Preston E, Wilks D et al. Chronic central melanocortin-4 receptor antagonism and central neuropeptide-Y infusion in rats produce increased adiposity by divergent pathways. Diabetes 2002; 51: 152158.
  • 2
    Vettor R, Zarjevski N, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B. Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia 1994; 37: 12021208.
  • 3
    Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 1993; 133: 17531758.
  • 4
    Correia ML, Morgan DA, Sivitz WI, Mark AL, Haynes WG. Hemodynamic consequences of neuropeptide Y-induced obesity. Am. J. Hypertens 2002; 15: 137142.
  • 5
    Lin EJ, Sainsbury A, Lee NJ et al. Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity. Endocrinology 2006; 147: 50945101.
  • 6
    Tiesjema B, La Fleur SE, Luijendijk MC et al. Viral-mediated neuropeptide Y expression in the rat paraventricular nucleus results in obesity. Obesity 2007; 15: 24242435.
  • 7
    Tiesjema B, Adan RA, Luijendijk MC, Kalsbeek A, La Fleur SE. Differential effects of recombinant adeno-associated virus-mediated neuropeptide Y overexpression in the hypothalamic paraventricular nucleus and lateral hypothalamus on feeding behavior. J Neurosci 2007; 27: 1413914146.
  • 8
    Tenenbaum L, Chtarto A, Lehtonen E et al. Recombinant AAV-mediated gene delivery to the central nervous system. J Gene Med 2004; 6: S212S222.